Novo Nordisk to acquire Inversago Pharma for up to $1.075 bn
The acquisition of Inversago includes the company’s lead development asset INV-202, an oral CB1 inverse agonist
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
M&A
Sigachi Industries forays into API business, acquires majority stake in Trimax Bio Sciences
The API unit is approved by USFDA for advanced and critical intermediates
M&A activity of pharma CMOs will continue despite challenging borrowing environment: GlobalData
CMOs showed an increasing reluctance to take on debt in 2022. Even still, large CMOs made acquisitions of companies and facilities…
Dimensions HRD Consultants acquires Qwazent Talent Solutions
The acquisition of Qwazent will enable Dimensions to expand its footprint in the pharma and healthcare industry
Eris Lifesciences acquires nine dermatology brands from Dr Reddy’s for Rs 2,750 mn
Eris entered the dermatology segment through the acquisition of Oaknet Healthcare for Rs 6,500 million in May 2022 and…
Waters Corp to acquire Wyatt Technology
The acquisition of Wyatt Technology, a growing leader in light scattering technology and software solutions, accelerates next…
Torrent Pharma to acquire Curatio Healthcare
Acquisition strengthens Torrent Pharma’s presence in the dermatology segment
Halozyme to acquire Antares Pharma for $960 mn
The acquisition of Antares would give Halozyme access to a range of medicines, such as testosterone therapy Xyosted, that have…
Rubicon Research acquires MeditabSpecialities’ facility in Satara, Maharashtra
The facility manufactures oral liquid dosage and nasal products
EQT Private Equity and Goldman Sachs to acquire Parexel
The deal is worth $8.5 billion